Policy & Regulation
Virax Biolabs to commercialize ImmuneSelect Portfolio in UK and Ireland via Europa Biosite partnership
23 October 2024 - Biotechnology company Virax Biolabs Group Limited (NASDAQ: VRAX) on Wednesday announced a new distribution agreement with Europa Biosite for the commercialisation of its ImmuneSelect...
Repare Therapeutics reports positive safety and tolerability data from Phase 1 MYTHIC trial
23 October 2024 - Repare Therapeutics Inc (Nasdaq: RPTX), a clinical-stage precision oncology firm, announced on Wednesday that it has reported updated safety and tolerability results from its Phase 1...
United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service
23 October 2024 - Public benefit corporation United Therapeutics Corporation (Nasdaq: UTHR) and its subsidiary Lung Bioengineering Inc (LBE) announced on Wednesday that they have achieved a significan...
JCR Pharmaceuticals showcases preclinical gene therapy advances at ESGCT Congress
23 October 2024 - JCR Pharmaceuticals Co, Ltd (TSE 4552) presented promising preclinical data on its adeno-associated virus (AAV) gene therapy research at the European Society of Gene and Cell Therapy...
Redwire partners with Bristol Myers Squibb for space-based drug research
23 October 2024 - Space infrastructure company Redwire Corporation (NYSE: RDW) on Wednesday announced a collaboration with biopharmaceutical company Bristol Myers Squibb (BMS) to study small molecule ...
Palatin Technologies highlights advances in obesity treatment at Peptide Therapeutics Symposium
23 October 2024 - Biopharmaceutical company Palatin Technologies Inc (NYSE American: PTN) announced on Wednesday that it presented new data on highly selective Melanocortin 4 Receptor (MC4R) agonists ...